David A. Siegel Onconova Therapeutics, Inc. Call Options Transaction History
Two Sigma Advisers, LP
- $42.5 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ONTX
# of Institutions
27Shares Held
1.71MCall Options Held
2.6KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA709KShares$418,0840.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny268KShares$158,2340.0% of portfolio
-
Black Rock Inc. New York, NY249KShares$146,8380.0% of portfolio
-
Geode Capital Management, LLC Boston, MA193KShares$113,7860.0% of portfolio
-
State Street Corp Boston, MA52.8KShares$31,1460.0% of portfolio
About Onconova Therapeutics, Inc.
- Ticker ONTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,895,600
- Market Cap $12.3M
- Description
- Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel products to treat cancer. It has two clinical-stage programs, including narazaciclib (ON 123300), a multi-targeted kinase inhibitor that is in Phase I study for solid tumors, as well as hematological malignancies as a single agent...